Intellectual Property India Publishes Patent Application for Monoclonal Antibody-Based Nanoparticles Comprising Coenzyme Q10 As A Matrix Material For Targeted Drug Delivery And Reduced Adverse Effc In Breast Cancer Treatment

MUMBAI, India, Nov. 6 -- Intellectual Property India has published a patent application (202641129775 A) filed by St Pauls College Of Pharmacy, Autonomous on October 30, 2026, for Monoclonal Antibody-Based Nanoparticles Comprising Coenzyme Q10 As A Matrix Material For Targeted Drug Delivery And Reduced Adverse Effc In Breast Cancer Treatment.

Inventors include Sneha Thakur; Kiranmai Mandava; and Venkat Ratnam Devadasu.

The application for the patent was published on November 06, 2026, under issue no. 45/2026.

Abstract: ABSTRACT The present invention relates to monoclonal antibody-based nanoparticles (100) comprising Coenzyme Q10 (104) as a matrix material for targeted drug delivery and reduction of adverse effects in breast cancer treatm...